Literature DB >> 22561120

Low dose cepharanthine ameliorates immune thrombocytopenic purpura associated with multiple myeloma.

Rie Tabata1, Chiharu Tabata, Ayako Tazoh, Tomoko Nagai.   

Abstract

Immune thrombocytopenic purpura associated with multiple myeloma is extremely rare. Here, we present the successful management of an elderly Japanese patient with multiple myeloma complicated by immune thrombocytopenia with low dose cepharanthine - a plant derived alkaloid. A 78-year-old male patient with IgGκ multiple myeloma was repetitively treated with melpharan and prednisolone. In each chemotherapy course, we demonstrated a close relationship between platelet recovery and administration of high dose prednisolone. When further chemotherapy was avoided because of the patient's poor general condition, administration of cepharanthine was effective in halting progressive thrombocytopenia due to abnormal immune mechanisms. We propose the usefulness of cepharanthine in management of this rare disease.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22561120     DOI: 10.1016/j.intimp.2012.04.015

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  8 in total

1.  Cepharanthine blocks TSH receptor peptide presentation by HLA-DR3: Therapeutic implications to Graves' disease.

Authors:  Cheuk Wun Li; Roman Osman; Francesca Menconi; Erlinda Concepcion; Yaron Tomer
Journal:  J Autoimmun       Date:  2020-01-21       Impact factor: 7.094

2.  Cepharanthine Ameliorates Chondrocytic Inflammation and Osteoarthritis via Regulating the MAPK/NF-κB-Autophagy Pathway.

Authors:  Minjun Yao; Caihua Zhang; Lingzhi Ni; Xiaoxiao Ji; Jianqiao Hong; Yazhou Chen; Jie Wang; Congsun Li; Jiyan Lin; Tingting Lu; Yihao Sheng; Menghao Sun; Mingmin Shi; Chenhe Zhou; Xunzi Cai
Journal:  Front Pharmacol       Date:  2022-06-21       Impact factor: 5.988

Review 3.  Genetics and epigenetics of autoimmune thyroid diseases: Translational implications.

Authors:  Hanna J Lee; Mihaela Stefan-Lifshitz; Cheuk Wun Li; Yaron Tomer
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2022-04-11       Impact factor: 5.667

4.  Identifying a Small Molecule Blocking Antigen Presentation in Autoimmune Thyroiditis.

Authors:  Cheuk Wun Li; Francesca Menconi; Roman Osman; Mihaly Mezei; Eric M Jacobson; Erlinda Concepcion; Chella S David; David B Kastrinsky; Michael Ohlmeyer; Yaron Tomer
Journal:  J Biol Chem       Date:  2015-12-24       Impact factor: 5.157

Review 5.  Multiple myeloma developing during long-term clinical course of refractory immune thrombocytopenic purpura: a case report and review of literature.

Authors:  Han Yao; Xi Zhang; Jia Liu; Lidan Zhu; Guo Chen; Sha Wu; Lei Gao
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

Review 6.  Cepharanthine: An update of its mode of action, pharmacological properties and medical applications.

Authors:  Christian Bailly
Journal:  Phytomedicine       Date:  2019-05-10       Impact factor: 5.340

7.  Cepharanthine Blocks Presentation of Thyroid and Islet Peptides in a Novel Humanized Autoimmune Diabetes and Thyroiditis Mouse Model.

Authors:  Cheuk Wun Li; Roman Osman; Francesca Menconi; Larissa C Faustino; Kookjoo Kim; Oliver B Clarke; Hanxi Hou; Yaron Tomer
Journal:  Front Immunol       Date:  2021-12-20       Impact factor: 7.561

8.  Cepharanthine Prevents Estrogen Deficiency-Induced Bone Loss by Inhibiting Bone Resorption.

Authors:  Chen-He Zhou; Jia-Hong Meng; Yu-Te Yang; Bin Hu; Jian-Qiao Hong; Zheng-Tao Lv; Kun Chen; Boon Chin Heng; Guang-Yao Jiang; Jian Zhu; Zhao-Hui Cheng; Wei Zhang; Le Cao; Wei Wang; Wei-Liang Shen; Shi-Gui Yan; Hao-Bo Wu
Journal:  Front Pharmacol       Date:  2018-03-27       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.